These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11528259)
1. Ocular infections due to contaminated solutions. Micallef C; Cuschieri P Ophthalmologica; 2001; 215(5):337-50. PubMed ID: 11528259 [No Abstract] [Full Text] [Related]
2. [The risks of infection due to ophthalmic solutions]. Goyet S; Blech MF; Hartemann PH Servir; 1991; 39(6):299-303. PubMed ID: 1775984 [No Abstract] [Full Text] [Related]
3. Multiple use of single use solutions: a dangerous practice. Seal DV Br J Ophthalmol; 2005 Jun; 89(6):783. PubMed ID: 15923530 [No Abstract] [Full Text] [Related]
4. Bacterial contamination of ophthalmic solutions used in an extended care facility. Jokl DH; Wormser GP; Nichols NS; Montecalvo MA; Karmen CL Br J Ophthalmol; 2007 Oct; 91(10):1308-10. PubMed ID: 17475711 [TBL] [Abstract][Full Text] [Related]
5. Sharing eyedrops between patients: when will it end? Kinlay J Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1333. PubMed ID: 24225627 [No Abstract] [Full Text] [Related]
7. Issues in the use of preservative-free topicals. Perry HD; Donnenfeld ED Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal injections and endophthalmitis. Kim SJ Int Ophthalmol Clin; 2015; 55(2):1-10. PubMed ID: 25730615 [No Abstract] [Full Text] [Related]
9. What drugs are used to prevent and treat chlamydial eye infections in newborns? Orshan SA NAACOG Newsl; 1992 May; 19(5):12. PubMed ID: 1625692 [No Abstract] [Full Text] [Related]
11. Keeping an eye on infectious keratitis. Snow M Nursing; 2007 Nov; 37(11):60-1. PubMed ID: 17968281 [No Abstract] [Full Text] [Related]
12. Contaminated Irrigasol solution. Thomas R Indian J Ophthalmol; 1998 Sep; 46(3):173. PubMed ID: 10085632 [No Abstract] [Full Text] [Related]
13. [Compounding of ophthalmic drugs in the pharmacy. Special care must be taken!]. Daniels R Pharm Unserer Zeit; 2010 Jul; 39(4):306-11. PubMed ID: 20589805 [No Abstract] [Full Text] [Related]
14. [Bacterial contamination of multi-dose ocular solutions. A prospective study at the Grenoble Teaching Hospital]. Brudieu E; Duc DL; Masella JJ; Croize J; Valence B; Meylan I; Mouillon M; Franco A; Calop J Pathol Biol (Paris); 1999 Dec; 47(10):1065-70. PubMed ID: 10674260 [TBL] [Abstract][Full Text] [Related]
15. Determination and application of the permitted daily exposure (PDE) for topical ocular drugs in multipurpose manufacturing facilities. Lovsin Barle E; Bizec JC; Glogovac M; Gromek K; Winkler GC Pharm Dev Technol; 2018 Mar; 23(3):225-230. PubMed ID: 28361586 [TBL] [Abstract][Full Text] [Related]
16. Infection following strabismus surgery. Ing MR Ophthalmic Surg; 1991 Jan; 22(1):41-3. PubMed ID: 2014110 [TBL] [Abstract][Full Text] [Related]
17. The unwanted ocular effects from topical ophthalmic drugs. Their occurrence, avoidance and reversal. Lyle WM; Hopkins GA J Am Optom Assoc; 1977 Dec; 48(12):1519-23. PubMed ID: 599247 [TBL] [Abstract][Full Text] [Related]
18. [Glaucoma and ocular surface]. Stefan C; Cojocaru I; Pop A Oftalmologia; 2011; 55(1):30-3. PubMed ID: 21774383 [TBL] [Abstract][Full Text] [Related]
19. Severe ocular infections with contact lens: role of multipurpose solutions. Dutot M; Paillet H; Chaumeil C; Warnet JM; Rat P Eye (Lond); 2009 Feb; 23(2):470-6. PubMed ID: 18483496 [TBL] [Abstract][Full Text] [Related]